SPY314.84-2.75 -0.87%
DIA261.04+0.22 0.08%
IXIC10,390.84-226.60 -2.13%

Matinas BioPharma Reports Resumption Of Enrollment In ENHANCE-IT, ENACT Trials

Benzinga · -